Skip to content
OpenCapital
Get started

LanzaTech Global, Inc. LNZA Joint development and contract research revenue — Total revenues

Other product segments

CarbonSmart product
$4.05M-3.7%
Revenue from grant contributions included in Engineering and other services above
$2.88M+5,127%
Contract research
$989K-28.1%
Licensing
$595K-43.4%
Joint development agreements
$0-100%

Similar metrics at other companies

Vir Biotechnology, Inc. logo
VIRLicense and collaboration revenue — Total revenues
-$41K+41.4%
BioCryst Pharmaceuticals logo
BCRXCollaborative and other revenues — Total revenues
$2M+14.3%
Aquestive Therapeutics, Inc. logo
AQSTCo-development and research fees — Revenue
$258K-38.3%
Arcus Biosciences logo
RCUSLicense and development services — Total revenues
$12M-40.0%
Tarsus Pharmaceuticals, Inc. logo
TARSLicense fees and collaboration revenue — Total revenues
$16.67M—
Crinetics Pharmaceuticals logo
CRNXCollaboration and license revenue — Total Revenue
$428K+18.6%

Other financials

Income statement

See full
Revenue$12.0M+26.8%
Operating income-$9.8M+68.4%
Net income-$14.7M+23.7%
EPS (diluted)-$1.77+81.9%

Balance sheet

See full
Cash & equivalents$19.9M+23.9%
Total debt$16.3M-46.1%
Total equity$48.1M+4,194%
Total assets$105.2M-16.4%

Cash flow

See full
Operating cash flow-$9.3M+56.1%
CapEx$55.0K-92.3%
Free cash flow-$9.3M+57.3%

Valuation

See full
Market cap$75.63M-75.8%
Enterprise value$72.09M-75.1%
P/S1.3×-6.4×

Profitability

See full
Operating margin-99.2%-36.2pp
Net margin-76.1%-31.8pp
FCF margin-91.8%-29.8pp

Returns & leverage

See full
Return on equity-215.3%—
Debt / equity0.3×—
Current ratio2×-0.2×

Where this comes from

Reported directly by LanzaTech Global, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: LanzaTech Global, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues?
LanzaTech Global, Inc. (LNZA) reported joint development and contract research revenue — total revenues of $989K in Q1 2026.
How has LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues changed year-over-year?
LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues decreased by 59.2% year-over-year, from $2.43M to $989K.
What is the long-term trend for LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues?
Over 2 years (2022 to 2024), LanzaTech Global, Inc.'s joint development and contract research revenue — total revenues has grown at a -6.5% compound annual growth rate (CAGR), from $12.12M to $10.59M.
What does joint development and contract research revenue — total revenues mean?
This metric represents the total revenue generated from collaborative research initiatives, feasibility studies, and joint development agreements with third-party partners. It reflects the company's ability to monetize its proprietary carbon-refining technology through early-stage innovation and technical consulting services. This revenue stream serves as a key indicator of the company's success in validating its technology platform and building a pipeline for future commercial licensing and production opportunities.